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Kappa chains comprise >90% of the light chains of mouse immunoglobulins (1, 2). 
These  chains  show  remarkable  diversity of amino  acid  sequence,  and  this  is  now 
known to be the result of several genetic factors, including  (a)  multiplicity of germ- 
line genes coding for the variable (V) 1 region (residues  1-95)  (3-8), (b) combinatorial 
association of different V  regions with four different J  regions (residues 96-108)  (5, 9, 
10)  and  (c) junctional  diversity resulting  from variation  generated  at  the  point  of 
recombination of V  and J  regions  (residues 95-96)  (11-13).  The magnitude of this 
genetically programmed diversity is great because each of the factors may potentially 
act in a multiplicative fashion. In addition to this programmed diversity, an additional 
order  of magnitude  of variation  could  occur  as  a  result  of spontaneous  somatic 
mutation acting at the level of the lymphocyte cell population (14). 
It would  be possible to assess the  importance of somatic mutation  in  generating 
kappa chain sequence diversity if one could sequence a large number of kappa chains 
that were all coded by a  single V-region gene, Vk. We have attempted to approach 
this problem by characterizing  a  group of light  chains  that  are structurally  closely 
related and which are controlled in a  mendelian  fashion  (15,  16).  The light chains, 
which  are derived from a  series of BALB/c myeloma proteins, all cofocus precisely 
with a pair of prominent polymorphic bands observed in normal light chain isoeleetric 
focusing (IF) profiles. The normal light-chain IF bands in question have been shown 
to be controlled by a chromosome 6 locus designated IgK-Ef2  (15). A second, similar 
locus, IgK-Efl,  has been shown to control other groups of closely related light chains 
observed as distinct bands in normal light-chain IF profiles (17).  One of these groups 
has recently been shown to represent a  unique group of kappa chains having an N- 
terminal  serine  residue  (18).  Because  both  the  IgK-Efl  and  IgK-Ef2  loci  seem  to 
control  several  sets  of normal  light-chain  IF  bands,  it  is  possible  that  they  may 
represent  distinct  blocks  of V  region  of kappa  chain  (Vk)  genes  that  have  been 
maintained in the genome of certain mouse strains. That the mouse Ck gene as well 
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as certain  Vk genes have been physically located on chromosome 6  (19,  20)  would 
support a  structural  gene basis for the polymorphisms. 
In this study, we have sequenced a group of four BALB/c light chains corresponding 
to bands controlled by the IgK-Ef2 locus. We have also sequenced two closely related 
kappa  chains  derived  from NZB  mice,  an  IgK-Ef2 °  strain.  The sequences  indicate 
that  the BALB/c light  chains  fall  into a  single V-region subgroup showing limited 
sequence  diversity.  The  NZB  proteins  represent  a  closely related  subgroup  distinct 
from the BALB/c subgroup. The results  are discussed  in terms of the nature  of the 
genetic polymorphism and the origin of intrasubgroup diversity. 
Materials and Methods 
Myeloma Proteins.  BALB/c and CAL-20 myeloma tumors TEPC-817,  generation 6  (G6), 
TEPC-821 (G6), FLOPC-1 (G15), and TEPC-105 (CAL-20) (G8) were generously provided by 
Dr.  Michael  Potter,  National  Institutes  of Health,  Bethesda,  Md.  These tumors have been 
maintained at Litton Bioneties, Kensington, Md. under National Cancer Institute, Bethesda, 
Md.  contract  NO1-CB-92142  to  Dr.  Michael  Potter.  Ascites  fluids  were  generated  at  the 
Universit~  de  Sherbrooke,  Sherbrooke,  Quebec,  Canada  by  intraperitoneal  inoculation  of 
pristane-primed BALB/cByJ and CAL-20 mice (21). Aseites fluids from NZB tumors PC 2205 
and PC 2567 were generously furnished by Dr. Martin Weigert, Institute for Cancer Research, 
Philadelphia,  Pa.  Myeloma proteins  were purified  by precipitation  three  times  of twofold- 
diluted aseites  fluid with an equal vol of 3.5 M ammonium sulphate, pH 7.3 (22). Light chains 
were isolated after partial reduction and alkylation of the immunoglobulin with iodoacetamide 
by gel filtration on columns of ACA 34 (LKB Produkter AB, Stockholm, Sweden) equilibrated 
with 3 M  guanidine hydrochloride and 0.2 M  ammonium bicarbonate. 
Enzyme Digestion, Fragment Purification, and Peptide Mapping.  Native light chain  (10 mg/ml) 
was digested with staphylococcal V8 protease  (23) (Miles  Research Laboratories)  in 0.05  M 
ammonium bicarbonate, 0.2% sodium dodecyl sulphate at an enzyme:light chain ratio of 1:25 
for 24 h at 37°C, The digest was lyophilized and fractionated on Sephadex G-75 equilibrated 
with 8 M urea, 0.05 M acetic acid (Fig.  I a). The major peak (B, Fig. 1 a) was then desalted on 
a column of Bio-Gel P2 (Bio-Rad Laboratories, Richmond, Calif.) equilibrated with 1 M acetic 
acid. The material was then completely reduced and alkylated using [14C]iodoacetamide and 
dialyzed against 0.05 M  ammonium bicarbonate using boiled Spectraphor 3 tubing (Bausch 
and Lomb, Inc., Rochester, N. Y.). This resulted in precipitation of the fragment V8-1 (Fig. 2). 
The supernate, containing peptides V8-2 and V8-3, was fractionated on DEAE-Sephacel using 
a  gradient of ammonium bicarbonate from 0.05  to 0.5 M  (Fig.  1 c). The fragment V8-1 was 
succinylated, digested with trypsin, and fractionated on DEAE-Sephacel using a  gradient of 
ammonium bicarbonate from 0.05 to  1 M  (Fig.  1 b).  Tryptic and chymotryptic digestion of 
completely reduced and alkylated light chain was carried out for 3 h at 37°C at an enzyme: 
light  chain  ratio  of 1:50.  Peptides were  isolated  from preparative  (5  mg)  peptide  maps by 
cutting out spots staining with 0.02% ninhydrin in acetone (25). Peptide mapping on Whatman 
3 MM paper (Whatman Chemicals, Div. W & R Balston, Maidstone, Kent, England) combined 
electrophoresis at pH 3.5 (2.7 kV, 90 min) followed by descending chromatography in butanol/ 
acetic acid/water/pyridine  (15:3:12:10). Tryptic and chymotryptic peptides identified in all 
proteins are indicated  in Fig.  2. Amino acid compositions were determined on a Technicon 
TSM-1 amino acid analyzer (Teehnicon Instruments Corp., Tarrytown, N. Y.)  (26). 
Fragmentation With Iodosobenzoic Acid (IOBA) (27).  Completely reduced and alkylated light 
chains were dissolved in 80%  acetic acid-4 M  guanidine-hydrochloride. An equal weight of 
IOBA (Pierce Chemical Co., Rockford, Ill.)  was then added and the reaction was allowed to 
proceed for either 3 or 24 h  at  room temperature  in a  brown bottle.  After terminating  the 
reaction by the addition of an excess of mercaptoethanol, the mixture was diluted twofold with 
water,  centrifuged,  and  the  supernate  was  fractionated  on  a  column  of Sephadex  G-50 
equilibrated  with 8 M  urea-0.5  M  propionic acid. Individual peaks were pooled and subse- 
quently fraetionated on columns of SE-Sephadex equilibrated with 8 M  urea-0.005 M  formic 
acid buffer, pH 3.0,  using gradients of KC1, 0-3 M  (28). Cleavage for 24 h  led to extensive 148  INTRASUBGROUP DIVERSITY OF  MOUSE KAPPA CHAINS 
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FIc.  l.  (a) Fractionation of a staphylococcal  V8 protease digest of 50 mg of the partially reduced 
and alkylated light chain of TEPC-821  on Sephadex G-75  in the presence  of 8 M  urea-0.05  M 
acetic acid. (b) Fractionation of a trypsin digest of the succinylated fragment V8-1. V8-1 represented 
the insoluble material obtained upon complete reduction and alkylation of peak B (Fig.  l a). The 
separation was performed on a column (0.6 X 8 cm) of DEAE-Sephacel equilibrated with 0.01 M 
ammonium bicarbonate. A linear gradient of ammonium bicarbonate 0.01-1.0  M (total vol 80 ml) 
was used for elution. (c) Fractionation of the soluble peptides obtained after complete reduction and 
alkylation of the material from peak B (a). Column conditions were as in (b) except for the salt 
gradient, which was from 0.01 to 0.5 M in this case. 
hydrolysis  at  tyrosine as well as  tryptophan  residues  (29)  and  fraetionation  was  difficult. At 
least one useful fragment  (IOBA-3, Fig. 2) resulting from tyrosine cleavage was purified. A less 
complex mixture was obtained in the 3-h IOBA digests, and these were used for the isolation 
of fragments IOBA-1 and IOBA-2. 
Sequenator Procedures.  Automated  sequencing of reduced  and  alkylated  intact  light  chains 
and fragments was performed using a  modified Illitron model 9001  sequenator with a  0.33 M 
quadrol program. For peptides and fragments, the sequenator was pre-run for three cycles with 
4  mg Polybrene plus  100  nmol of glycylglycine (30).  The samples  from the sequenator  were 
converted manually using 25% trifluoroacetic acid (TFA) for 10 min at 60°C. After drying the 
TFA, the samples were dissolved in 0.1 ml methanol:acetonitrile (50:50) and analyzed by high- 
performance  liquid  chromatography  (HPLC).  HPLC  separation  of  phenylthiohydantoin 
(PTH) amino acids was carried out on a Waters (Waters Associates, Milford, Mass.) instrument 
using  Dupont  CN-columns  (31).  In  some  instances,  samples  were  identified  by  amino  acid 
analysis after alkaline dithionite hydrolysis (32). 
Results 
Sequencing of the Light Chains.  The strategy  used in sequencing the light chains is 
summarized  in Fig. 2. Because glutamic acid occurred at only three positions in the 
V region (positions 79, 81 and 105; numbering according to Kabat et al. [3]), cleavage 
of the  native  light  chain  with  staphylococcal  protease  V8,  an  enzyme  specific  for 
glutamyl peptide bonds  (23), resulted in the formation of a large disulphide-bonded 
V-region  fragment  that could be isolated on Sephadex G-75  in the presence of urea 
(Fig.  1).  Complete  reduction  and  alkylation  of the  fragment  with  iodoaeetamide 
resulted in precipitation of a mixture of large N-terminal fragments (residues 1-79,  1- 
81, and  1-105).  The soluble fraction contained a fragment corresponding to residues 
81-105.  This was purified  (Fig.  1 c) and could be sequenced up to and including the 
C-terminal  glutamic  acid  residue  (Fig.  3).  The  insoluble  fraction  was  succinylated 1
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Fro. 3.  Recoveries of PTH-amino acids in the automated degradation of fragment V8-2 obtained 
from the light chain of FLOPC-1. Because of incomplete resolution of PTH-glutamine (PTH-GIn) 
and PTH-glycine  (PTH-GIy), data is included for the recovery of glycine after alkaline dithionite 
hydrolysis. The PTH-derivatives of dehydro-serine, dehydro-threonine, and S-carboxymethylamido 
cysteine were determined by monotoring  the effluent of the HPLC at A~z3  ~. Other PTH amino 
acids were followed at A~,4  m. The data for histidine are from the recovery ofhistidine after alkaline 
dithionite hydrolysis. The  location  of cysteine was also determined by the location  of the  x4C 
radioactivity, as the fragment  was in the [x4C]carboxymethylamido form. The sequence deduced 
from this data corresponds to residues 80-105 (Fig. 4). 
and subjected to cleavage with trypsin. The resulting fragments were fractionated on 
DEAE-Sephacel (Fig. 1 b) and subjected to automated sequencing. Tryptic fragments 
containing residues 25-54, 62-77, and  78-105 were isolated in this way. The iodoso- 
benzoic acid cleavage fragment beginning at residue 36 was sequenced for 24 cycles 
over  the  region  36-60.  An  additional  fragment  resulting  from  IOBA  cleavage  at 
tryosine 49 gave a  sequence over residues 50-68, linking the sequences obtained with 
the other fragments. Complete sequencing of all proteins was done over residues 1-44 
and  78-105.  The  internal  residues, 45-77,  were  completely sequenced  as described 
only  for  proteins  TEPC-817  and  FLOPC-1.  In  the  remainder of the  proteins,  the 
region of residues 45-77 was determined by composition and mobilities of tryptic and 
chymotryptic peptide only. 
Sequence Diversity in Ef2-related Light Chains.  Comparison of the four BALB/c light T-lOS 
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FIo. 4.  Amino  acid sequences of the variable regions of the BALB/c myeloma  light chains TEPC 
(CAL 20)-105, FLOPC-1, TEPC-817, and TEPC-821 and NZB myeloma  light chains PC 2205 and 
PC 2567. The single letter code is according  to a previously  proposed method (24). Numbering and 
location of cdr regions (horizontal  bars over the sequence) is according to Kabat et al. (3). 
chain sequences (Fig. 4) indicates they fall into a very closely related subset of kappa 
chains. By the classification of Potter (33) these sequences represent a subgroup of the 
Vkl  group,  a  group  that  includes  the  light  chain  of the  dinitrophenyl-binding 
myeloma protein MOPC-460  (34).  The sequences of TEPC-817 and TEPC  (CAL- 
20)-105 are identical up to position 95, where the normally highly conserved proline 
residue is deleted in TEPC-817. The other two sequences (FLOPC-1 and TEPC-821) 
differ  from  the  prototype  (TEPC-105)  sequence  by  three  (two  complementarity- 
determing regions [cdr] and one framework [fr] region) and one (fr) residues respec- 
tively.  ~ None of the substitutions involves a net change in charge, as expected because 
the proteins were all selected on the basis of their charge identity in IF. 
Strain-specific Sequence Differences.  Comparison of the N-terminal sequences of Ef2- 
related  BALB/c  light  chains  with  sequences  available  for NZB  light  chains  (26) 
revealed that two examples of closely related light chains had been observed in NZB 
myelomas (PC 2205 and PC 2567). Because NZB mice are negative for the El2 marker 
in  normal  light  chain  profiles and  no examples of Ef2-identical light  chains  were 
detected by IF screening of 133 NZB myelomas (16), the existence of these two light 
chains suggested that NZB mice must carry V  genes for a subgroup closely related to 
the El2 subgroup. We previously showed that light chains of NZB myelomas PC 2205 
and PC 2567 differed slightly from the El2 marker bands on IF (16). Sequencing of 
the V  regions of the NZB  proteins has revealed that  they differ from the BALB/c 
proteins by only four residues (Fig. 4). The presence of a tyrosine in place of histidine 
at  position  34  is  sufficient  to  explain  the  slight  anodal  charge  shift  in  the  NZB 
proteins. The two NZB proteins themselves differ by two residues in the V region, one 
of these is a tyrosine-histidine substitution. This would explain the slight IF difference 
we observed between the two proteins (16). 
2  The fr and cdr regions are as defined by Kabat (3). 152  INTRASUBGROUP  DIVERSITY OF MOUSE KAPPA CHAINS 
Discussion 
Complete V-region amino acid sequences of four BALB/c  light chains correspond- 
ing to normal light chain IF-bands controlled  by the IgK-Ef2 locus indicate  that the 
light chains differ from one another by one to three residues  (Fig. 4). The question 
that arises is whether they may be all coded by a single Vk gene. It seems likely that 
at least two of the proteins, TEPC-817 and TEPC  (CAL-20)-105 are coded by the 
same V  gene, because the only difference between the two proteins is the deletion of 
proline 95 in the TEPC-817 sequence. This seems likely because of deletion of codon 
95 at the time of joining V-817 and J4. This is the first instance of a deletion at this 
position, but it not unexpected in view of the apparent sloppiness of V-J joining (13). 
Other examples of this phenomenon have resulted in the deletion of residue 96 (in PC 
8701  [11])  and the insertion of an extra residue between position 95 and 96 (in PC 
7132 [5]). More recently, an out-of-phase V-J joining has been shown to result in the 
formation of a cryptic light chain gene (13). 
Although TEPC-817 and TEPC  (CAL-20)-105 light chains are probably derived 
from a single V gene, the other two light chains, FLOPC- 1 and TEPC-821 differ from 
the prototype sequence by three (one fr, two cdr) and one (fr) residues, respectively. 
The occurrence of two substitutions in the cdr regions of FLOPC-1 can be attributed 
to somatic mutation of the type seen in mouse lambda chains (14). Differences in the 
framework region however cannot be accommodated in the classical somatic muta- 
tion-selection model.  Such  differences are  generally attributed  to  the  existence of 
additional  germ-line  genes.  A  less  likely possibility  is  that  they  represent  residual 
heterozygosity within  the  BALB/c  population.  Evidence  that  germline-coded  Vk 
genes may differ by as few as two framework residues is found in kappa subgroups 
Vk-21E and Vk-21F.  Here, repeat substitutions of two framework residues occur in 
the NZB light chains PC 2485 and PC 4039 (Vk-21F) when compared with PC 7175 
and  PC  6684  (Vk-21E)  (5).  In the present work, we are unable to say whether the 
framework substitutions observed represent additional Vk genes because no repeat 
occurrences have been  found.  Sequencing of additional  Ef2-related light  chains  is 
under way to further document the diversity within this subgroup.  We propose to 
designate the subgroup Vk-IA based on the original sequence classification of Potter 
(33). 
Sequencing of two closely related light chains from NZB myelomas PC 2205 and 
PC 2567 indicates that these two light chains are derived from a  different Vk gene. 
These light chains share four identical substitutions compared with the Vk-1A proteins 
of BALB/c. That NZB mice and other IgK-Ef2 b strains (15) fail to express light chains 
of the Vk-IA subgroup is most easily understood in terms of a loss of the Vk-IA gene 
or gene cluster in these strains. It is also possible that the Vk-IA gene(s) are present 
but  not expressed because of regulatory effects (e.g., at  the level of translocation). 
Regulatory influences directed  at  a  specific Vk  subgroup  at  the  cellular level are 
difficult to imagine because it is likely that Vk-IA light chains occur in a variety of 
functional combinations with different heavy chain partners. That the Vk-IA and 
Vk-IB  subgroups  differ by  four substitutions  suggests  that  they  may  not  be  true 
alleles,  but  instead  represent  different structural  gene loci.  If this  is  the case,  it  is 
possible that  BALB/c may possess both the Vk-IA and Vk-IB genes.  However, we 
have so far found no examples of Vk-1B light chains in a screening of >200 BALB/c 
myelomas. CLAUDE LAZURE, WAH-TUNG HUM, AND DAVID M.  GIBSON  153 
Resolution  of the  question  of whether  the  subgroup  is coded  by a  single-Vk-lA 
gene or a  series of virtually identical genes repeated in tandem awaits the results of 
DNA studies now in progress. That the light chains correspond to a single pair of IF 
bands that behaves in a  mendelian fashion would tend to favor a  single-gene origin 
for the subgroup.  If the sequences  are derived  from a  single Vk-IA gene,  it would 
mean that the framework substitutions observed must be a result of somatic mutation 
either before or during the myeloma induction or propagation. Substitutions outside 
of the  cdr  regions  may not  be completely neutral  because they could  conceivably 
affect the antigen-binding site or the idiotypic character of the molecule by altering 
the three-dimensional structure of the V  region. It is clear from the very existence of 
a  great  variety of V-region  subgroups  that  selection  for framework diversity must 
occur in evolution. Similar forces could also act at the somatic level. 
Summary 
We  previously  showed  that  a  chromosome 6  locus,  IgK-EJ'2,  controls  a  pair  of 
prominent bands in normal mouse light-chain isoeleetric focusing profiles. Screening 
of myeloma light chains derived from BALB/c mice (an IgK-EF2 a strain)  led to the 
identification of seven light chains cofocusing with the polymorphic bands controlled 
by IgK-Ef2. Complete sequencing of the variable (V) regions of four of the light chains 
indicates  that  they are all members of the same subgroup  (Vk-IA)  and they differ 
from one another by 1-3 substitutions. One of the proteins differs from the prototype 
V-region sequence only in the deletion of a single residue at position 95 immediately 
preceding the J  region. The other two differ from the protoype V  region by 3  (two 
framework [fr], one complementarity-determining [cdr]) and one (fr) residues, respec- 
tively. Complete V-region sequences of two closely related light chains derived from 
NZB mice (an IgK-Ef2 b strain) indicate the NZB proteins are derived from a distinct 
Vk gene (Vk-1B), differing by four substitutions from the Vk-1A sequence. The results 
suggest that the IgK-Ef2 polymorphism may be a result of, at least in part, the loss of 
the gene(s) coding for the Vk-IA subgroup in IgK-Ef2 b strains of mice. The nature of 
the sequence diversity found in the Vk-IA subgroup indicates that either it is coded 
by a  repeated series of virtually identical genes or that somatic mutation of a  single 
Vk-1A gene may give rise to substitutions in framework as well as cdr regions. 
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